News Headlines Article

Senator Urges FTC to Examine Link Between Drug Shortages, Pharma Consolidation
Health Leaders Media

A critical shortage of drugs, especially chemotherapy and pain relief medications, is endangering patient safety and costing hospitals an estimated $200 million per year as they scramble to procure substitutes, often at higher prices.

Now Sen. Herb Kohl (D-WI) wants the Federal Trade Commission to examine the impact that consolidation in the pharmaceutical industry may be having on the nation’s drug supply.

Commands